Treatment persistence and maintenance dose titration among ulcerative colitis patients on biologics: A pooled study of three United States claims databases

Abstract Objective: This real-world study evaluated biologic treatment patterns in moderate-to-severe ulcerative colitis (UC) patients. Methods: IQVIA® PharMetrics®, IBM® MarketScan®, and Optum Clinformatics™ were pooled to identify UC patients with ≥1 claim for UC...

The impact of intestinal complications on health care costs among inflammatory bowel disease patients treated with anti-tumor necrosis factor therapies

Abstract     Authors: David T Rubin, Jenny Griffith, Qisu Zhang, Zsolt Hepp, Allison Keshishian Background: Although there is evidence that anti-tumor necrosis factor (TNF) utilization earlier in the inflammatory bowel disease (IBD) course and before the...